Jean-pierre P. Mach
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction to: CART cells are prone to Fas- and DR5-mediated cell death.
Journal: Journal for immunotherapy of cancer
Published: September 14, 2018
Corrigendum to "An altered REDOX environment, assisted by over-expression of fetal hemoglobins, protects from inflammatory colitis and reduces inflammatory cytokine expression" [Int. Immunopharmacol. 50 (2017) 69-76].
Journal: International immunopharmacology
Published: April 24, 2018
Corrigendum to "Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis" [Int. Immunopharmacol. 57 (2018) 112-120].
Journal: International immunopharmacology
Published: April 24, 2018
CART cells are prone to Fas- and DR5-mediated cell death.
Journal: Journal for immunotherapy of cancer
Published: January 16, 2018
Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis.
Journal: International immunopharmacology
Published: December 28, 2017
Analysis of cytokine immune response profile in response to inflammatory stimuli in mice with genetic defects in fetal and adult hemoglobin chain expression.
Journal: The pharmacogenomics journal
Published: May 30, 2017
An altered REDOX environment, assisted by over-expression of fetal hemoglobins, protects from inflammatory colitis and reduces inflammatory cytokine expression.
Journal: International immunopharmacology
Published: May 04, 2017
Enhancing actions of peptides derived from the γ-chain of fetal human hemoglobin on the immunostimulant activities of monophosphoryl lipid A.
Journal: Innate immunity
Published: October 18, 2015
Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 16, 2015
Classification of current anticancer immunotherapies.
Journal: Oncotarget
Published: November 02, 2014
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine.
Journal: Journal for immunotherapy of cancer
Published: July 24, 2014
Last Updated: 09/26/2026